메뉴 건너뛰기
New England Journal of Medicine
Volumn 374, Issue 13, 2016, Pages 1295-1296
Nonmedical prescription-opioid use and heroin use
Author keywords

[No Author keywords available]
Indexed keywords

DIAMORPHINE; OPIATE; OXYCODONE; NARCOTIC ANALGESIC AGENT;
EID: 84962450057     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1601875     Document Type: Letter
Times cited : (15)
References (6)
  • 1
    • 84954290679 scopus 로고    scopus 로고
    • Relationship between nonmedical prescription-opioid use and heroin use
    • Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med 2016; 374: 154-63.
    • (2016) N Engl J Med , vol.374 , pp. 154-163
    • Compton, W.M.1    Jones, C.M.2    Baldwin, G.T.3
  • 2
    • 84946059139 scopus 로고    scopus 로고
    • Shifting patterns of prescription opioid and heroin abuse in the United States
    • Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med 2015;373:1789-90.
    • (2015) N Engl J Med , vol.373 , pp. 1789-1790
    • Cicero, T.J.1    Ellis, M.S.2    Harney, J.3
  • 3
    • 84929377866 scopus 로고    scopus 로고
    • Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: Lessons learned from OxyContin
    • Cicero TJ, Ellis MS. Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContin. JAMA Psychiatry 2015; 72: 424-30.
    • (2015) JAMA Psychiatry , vol.72 , pp. 424-430
    • Cicero, T.J.1    Ellis, M.S.2
  • 4
    • 84888437924 scopus 로고    scopus 로고
    • Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxy-codone with abuse-deterrent characteristics
    • Coplan PM, Kale H, Sandstrom L, Landau C, Chilcoat HD. Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxy-codone with abuse-deterrent characteristics. Pharmacoepidemiol Drug Saf 2013;22:1274-82.
    • (2013) Pharmacoepidemiol Drug Saf , vol.22 , pp. 1274-1282
    • Coplan, P.M.1    Kale, H.2    Sandstrom, L.3    Landau, C.4    Chilcoat, H.D.5
  • 5
    • 84896093906 scopus 로고    scopus 로고
    • "every 'never' i ever said came true": Transitions from opioid pills to heroin injecting
    • Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting. Int J Drug Policy 2014; 25: 257-66.
    • (2014) Int J Drug Policy , vol.25 , pp. 257-266
    • Mars, S.G.1    Bourgois, P.2    Karandinos, G.3    Montero, F.4    Ciccarone, D.5
  • 6
    • 84863677170 scopus 로고    scopus 로고
    • Effect of abuse-deterrent formulation of OxyContin
    • Cicero TJ, Ellis MS, Surratt HL. Effect of abuse-deterrent formulation of OxyContin. N Engl J Med 2012; 367: 187-9.
    • (2012) N Engl J Med , vol.367 , pp. 187-189
    • Cicero, T.J.1    Ellis, M.S.2    Surratt, H.L.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.